Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Operating Margin: 2019-2025

Historic Operating Margin for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to -32.39%.

  • Biodesix's Operating Margin rose 1494.00% to -32.39% in Q3 2025 from the same period last year, while for Sep 2025 it was -40.61%, marking a year-over-year increase of 1235.00%. This contributed to the annual value of -48.37% for FY2024, which is 3585.00% up from last year.
  • Biodesix's Operating Margin amounted to -32.39% in Q3 2025, which was up 33.28% from -48.55% recorded in Q2 2025.
  • In the past 5 years, Biodesix's Operating Margin registered a high of -19.34% during Q1 2021, and its lowest value of -220.85% during Q1 2022.
  • Over the past 3 years, Biodesix's median Operating Margin value was -48.55% (recorded in 2025), while the average stood at -64.08%.
  • Per our database at Business Quant, Biodesix's Operating Margin surged by 14,593bps in 2021 and then tumbled by 20,150bps in 2022.
  • Biodesix's Operating Margin (Quarterly) stood at -161.67% in 2021, then soared by 1,709bps to -144.58% in 2022, then skyrocketed by 9,775bps to -46.84% in 2023, then spiked by 1,429bps to -32.55% in 2024, then skyrocketed by 1,494bps to -32.39% in 2025.
  • Its Operating Margin stands at -32.39% for Q3 2025, versus -48.55% for Q2 2025 and -50.87% for Q1 2025.